EP0532737A1 - Assay device and method of detecting chitin - Google Patents

Assay device and method of detecting chitin

Info

Publication number
EP0532737A1
EP0532737A1 EP19920909933 EP92909933A EP0532737A1 EP 0532737 A1 EP0532737 A1 EP 0532737A1 EP 19920909933 EP19920909933 EP 19920909933 EP 92909933 A EP92909933 A EP 92909933A EP 0532737 A1 EP0532737 A1 EP 0532737A1
Authority
EP
European Patent Office
Prior art keywords
chitin
enzyme
chitinase
sample
bound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19920909933
Other languages
German (de)
French (fr)
Inventor
Daniel Tuse
Linda Dousman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SRI International Inc
Original Assignee
SRI International Inc
Stanford Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SRI International Inc, Stanford Research Institute filed Critical SRI International Inc
Publication of EP0532737A1 publication Critical patent/EP0532737A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56961Plant cells or fungi
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes

Definitions

  • This invention relates to the field of assays to detect target substances, and particularly to assays to determine the presence of chitin and thereby determine the presence of organisms which contain chitin such as fungi, yeast, and insects in a sample.
  • Bac crround Infections caused by fungi and yeast affect animals including humans and plants worldwide. There exist a large number of such organisms which can contaminate water and food supplies and cause infections in various body tissues and fluids. Conventional methods to detect the presence of contaminating fungi, yeast and insects require obtaining samples from an animal or plant suspected of containing these organisms and culturing the samples to grow the desired organisms present in the sample in sufficient numbers to readily detect their presence visually.
  • culturing the organisms requires specialized media and lengthy culture times of up to several weeks.
  • Other methods involve the use of a hot basic solution such as a 20% potassium hydroxide to clear smears of specimens on a solid substrate. The cleared specimen is then stained, for example using India ink, then examined by microscope to detect the presence of fungal structures remaining after this treatment.
  • Fungi, yeasts and insects contain certain substances, including proteins, that may be specific for a particular species. Other substances are more widely distributed.
  • chitin N-acetylglucosamine oligomer
  • lectins Galun et al., Arch.
  • Immunological assays to detect various microorganisms including fungi using antibodies are also known, including those employing monoclonal antibodies reactive with antigens associated with particular organisms.
  • Such assays are based on species-specific proteins.
  • the assays typically require that the specific protein be isolated or exposed for reaction with the antibody in the assay.
  • the basic inventive concept of the assay methods and means for carrying out those methods is based on the recognition that certain organisms including fungi, yeasts and insects are rich in chitin.
  • the assay of the invention is for the direct detection of chitin and by implication deducing the presence of the chitin-containing organisms.
  • An essential feature of the present invention is that it involves the use of enzymes which specifically bind to chitin.
  • Such enzymes are referred to as chitin-binding biological reagents and chitin-binding or chitin-specific enzymes and include chitinase and lysozyme.
  • Such chitin- binding enzymes are directly or indirectly attached to a label before or after they bind to chitin.
  • the assays of the invention can be used to selectively attach detectable labels to chitin present within a sample.
  • the assay of the invention makes it possible to detect chitin by the use of enzymes which specifically bind chitin.
  • enzymes which specifically bind chitin such as chitinase
  • an enzyme which specifically binds chitin is bound to the surface of a support such as the bottom of a icrotiter plate well, the surface of a glass slide or the surface of a dipstick. Samples to be tested are then brought in contact with the enzyme, bound to the surface and various procedures are carried out in order to determine and detect the presence of any chitin binding to the enzyme on the surfaces.
  • a fluid sample or a fluidized sample is filtered through a membrane in order to capture the solid components of the sample on the surface of the membrane. Accordingly, any chitin- containing organisms, chitin, or fragments thereof within the sample become bound to the membrane surface.
  • the bound sample is then contacted with an enzyme capable of selectively binding to any chitin in the sample, for example chitinase or lysozyme.
  • the chitin-binding enzyme may be directly or indirectly labeled to permit detec ⁇ tion. The presence of the chitin-containing organisms such as fungi is determined by visually detecting the label with the naked eye.
  • a primary object of the present invention is to provide a rapid detection assay which uses a chitin- binding enzyme for determining the presence of ' chitin- containing organisms without the need for in vitro or in vivo culture techniques or time-consuming staining procedures.
  • a feature of the present invention is that the assay detects the cellular chitin component of all organisms containing chitin such as fungi, yeasts and insects, which chitin component is generally absent in bacteria and mammalian and plant tissue, reducing possible false positive readings.
  • An advantage of the present invention is that it can be used to detect chitin and deduce the presence of chitin-containing organisms in samples of all types of biological (mammalian and plant) fluids and tissues as well as food and water without the need for any culturing techniques or staining procedures.
  • the method is not limited to particular species of fungi, yeasts or insects since all such organisms contain chitin.
  • Another advantage of the present invention is that it provides an efficient, economical, clinical laboratory assay technique for the rapid diagnosis of fungal infections in patients.
  • Another feature of the present invention is that neither lectins nor anti-chitin antibodies are used to detect chitin which is a desirable feature in that lectins will often bind nonspecifically to nonfungal carbohydrates other than chitin, whereas anti-chitin antibodies are undesirable in that they are, at best, difficult to generate due to chitin's poor immunogenicity.
  • An advantage of the present invention is that the detection means do not require the use of either electron or fluorescent microscopy to effect detection.
  • Figure 1 is a schematic view of an embodiment of the invention wherein the chitin is bound on a permeable membrane matrix
  • Figure 2 is a schematic view wherein the chitin-containing sample is present in a coated microtiter well;
  • Figure 3 is a schematic representation of the components of an assay scheme which includes a membrane support, chitinase, rabbit anti-chitinase antibody, and alkaline phosphatase conjugated to goat anti-rabbit IgG antibody, which enzyme can generate a colored product from a chromogenic solution;
  • Figure 4 is a schematic representation of the components of another assay embodiment of the invention wherein the porous membrane captures the chitin, a chitin-binding enzyme attaches to the bound chitin, thereafter a conjugate comprised of a signal generating enzyme bound to an antibody reactive with the chitin- binding reagent binds to the chitin-binding reagent and a chromogenic solution is added, which solution contains the substrate for the signal generating enzyme, which substrate releases a color when contacted with the enzyme;
  • Figure 5 is a schematic representation of the components of yet another embodiment of an assay of the invention which includes a support having bound thereto chitin having bound thereto avidin-conjugated chitin- binding biological reagent having bound thereto biotinylated enzyme and a chromogenic solution;
  • Figure 6 is a schematic view of the components of yet another embodiment of the assay of the invention wherein a solid support has thereon chitin which has bound thereto an enzyme-conjugated chitin-binding biological reagent wherein the enzyme of the conjugate will react with its substrate in a chromogenic solution to form a colored product; and
  • Figure 7 is a schematic view of the components of yet another embodiment of the assay of the invention which includes a chitin-binding biological reagent which is chitinase coated on a solid support, chitin bound to the coated support, chitin-binding biological reagent bound to the chitin, rabbit anti-chitin-binding reagent antibody bound thereto, an enzyme conjugated to goat anti-rabbit IgG antibody and a chromogenic solution.
  • the method of the present invention allows the rapid detection of the presence of a variety of chitin- containing organisms including fungi, yeast and insects, without requiring costly and time-consuming culturing or staining of the organisms.
  • the method provides an assay for detecting chitin using chitin-specific enzyme reagents and is not limited to any particular strain or species of organism.
  • the method does not require that specific substances such as proteins or carbohydrates be isolated from a sample suspected of containing organisms, prior to detection in the assay.
  • the substance that is detected in the method of this invention is chitin, an N-acetyl-glucosamine oligomer present in the cell walls of nearly all fungi and yeasts as well as the exoskeleton of many insects and other arthropods.
  • a sample suspected of containing target organisms is obtained.
  • the sample may include a fluid and non-fluid component and may originate from humans, animals, plants or food items.
  • Typical samples include biological fluids such as urine, spinal fluid, whole blood or serum.
  • Other samples include biological specimens such as skin scrapings, sputum, tissue homogenates, wound exudates, or hair.
  • samples may consist of materials from plants including tissue, scrapings, fluids, exudates and homogenates, or may be water or food suspected of contamination.
  • different embodiments of the invention are more readily applicable for assaying for the presence of chitin in the sample.
  • the invention includes a wide variety of different possible embodiments and different chemical and biological reagents which can be used in connection with each of these embodiments, the invention is generally encompassed by two subgeneric embodiments.
  • the sample includes fluid and nonfluid components or is fluidized so as to contain both components and is thereafter filtered through a porous membrane in order to capture the nonfluid-containing components on the surface of the membrane.
  • the presence of chitin in these nonfluid-containing components is then assayed by the use of an enzyme which specifically binds to chitin.
  • This subgeneric embodiment is generally shown within Figure l and specific embodiments thereof are schematically represented within Figures 3-6.
  • the second subgeneric embodiment of the invention involves coating the surface of a material such as a microtiter well with an enzyme which specifically binds to chitin. Once the enzyme such as chitinase has been bound to the surface, the sample to be assayed is brought into contact with the bound chitinase for a sufficient period of time to allow binding to occur between any chitin in the sample and the chitinase bound to the surface.
  • This subgeneric embodiment of the invention is shown within Figure 2.
  • a specific embodiment schematically demonstrating how this subgeneric embodiment can be carried out is shown within Figure 7.
  • the subgeneric embodiment shown within Figure 2 can also be carried out using the specific embodiments shown within Figures 3-6, i.e., it need not be carried out only using the specific embodiment of Figure 7.
  • the chitin-specific enzyme When the chitin-specific enzyme is to be adhered to a substrate surface, it may be adhered to the surface of a glass slide, microtiter well, dipstick or other suitable material.
  • any suitable membrane filter can be used, such as those composed of various synthetic or natural polymeric materials.
  • the two subgeneric embodiments of the invention are shown in figures 1 and 2.
  • the solid components of a sample comprised of liquid and solid components have been attached to a membrane matrix.
  • the surface of the matrix is preferably designed such that it will hold the solid components and particularly the chitin within the sample securely in place on the surface of the matrix. It is often desirable to include a blocking agent (described further below) to protect active binding sites that have not been occupied by chitin.
  • the sites on the surface of the membrane which do not have chitin bound thereto are preferably blocked, for example by incubation of the fixed sample on the membrane with an irrelevant protein solution such as bovine serum albumin (BSA) , casein or egg albumin. Blocking reduces any nonspecific interactions (i.e., electrostatic interactions) of the binding sites which may interfere with the assay to detect chitin.
  • BSA bovine serum albumin
  • the surface of the well is coated with a chitin-specific enzyme.
  • a blocking agent is then applie to occupy all remaining binding sites of the well.
  • a sample which may contain chitin is placed in the treated well surface.
  • Chitinase is added and allowed to incubate with the sample for a time period in the range of about 3 minutes to about 1 hour to allow the chitinase to bind to any chitin present within the sample.
  • the wells are then washed with a buffer to remove any chitinase which is not bound to chitin bound to chitinase on the surface of the microliter well. After the washing, any immobilized chitin on the well plate would be detected by adding a reagent which causes a color reaction after contacting a label connected directly or indirectly to the chitinase.
  • This methodology can be used in connection with both insoluble and soluble signal detection strategies.
  • the signal will appear coated on the bottom and sides of the well. If a soluble signal reagent is used, the supernatant can be read visually with the naked eye .in situ or by highly reliable and commonly used automatic plate readers, or drawn off for processing in a separate detector.
  • the sample can also be manually smeared onto a glass slide with a cotton swab, scalpel blade, or other similar device, allowed to dry completely and then fixed with chemicals.
  • Heat may also be used for fixation, for example, the solid phase may be placed over a boiling (100°C) water bath until the sample adheres onto the solid phase.
  • the sample may be manually placed on the solid phase and adhered using chemical fixatives, or it may be suspended in a fluid and applied to a solid phase as described above.
  • the assay methodology of the present invention is based on the use of the chitin-specific enzyme which is directly or indirectly attached to a label.
  • the assay of the invention can be used to detect chitin-containing organisms present in situ on a surface without having to remove or destroy the surface on which the organisms might be present. For example, if one sus ⁇ pects a plant to have a fungal infection on its surface, a biological reagent of the present invention containing a chitin-specific enzyme can be sprayed onto the surface of the plant. Thereafter, washing should be carried out in order to wash away any unbound chitin-specific enzyme.
  • the assay of the invention relies upon binding of a chitin-binding enzyme reagent specifically binding to chitin and the visualization of this binding by a labeling system.
  • the binding reagent is preferably chitinase.
  • Polyclonal antibodies reactive with chitinase may be obtained by recovery of serum-containing antibodies following immunization of a mammalian host using chitinase as the immunogen. Procedures for producing polyclonal antibodies are well known and will not be repeated here.
  • the serum-containing polyclonal antibodies are used for binding to chitinase which is bound to chitin in an assay described below to detect chitin-containing organisms.
  • Monoclonal antibodies reactive with chitinase may also be used in an assay to bind to chitinase.
  • These monoclonal antibodies may be derived using known tech ⁇ niques following the procedures of Kohler and Milstein, Nature, 256:495 (1975), incorporated herein by reference, to disclose methods of obtaining monoclonal antibodies.
  • hybrido as are prepared by fusing antibody-producing cells (typically spleen cells of mice previously immunized with an antigen) to cells from an immortal cell line such as myeloma cells, using somatic cell hybridization.
  • chitin is substantially nonimmunogenic and that, therefore, it is difficult to generate chitin antibodies
  • anti-chitinase antibodies can be generated and that such anti-chitinase antibodies are useful in accordance with different embodiments of the present invention.
  • Polyclonal and/or monoclonal antibodies which are anti-chitinase antibodies are useful in carrying out different specific embodiments of the invention.
  • anti-chitinase antibodies will bind to the chitinase.
  • anti-chitinase antibodies are generally labeled, such as with an enzyme, which enzyme generates a color when brought into contact with a chromogenic solution.
  • Polyclonal anti-chitinase antibodies were generated using two New Zealand White rabbits.
  • the rabbits were immunized with 1 mg of chitinase from Streptomvces ⁇ riseus (obtainable from the Sigma catalog C1525) present in Ribi adjuvant.
  • the rabbits received a second immunization three weeks later and were then immunized twice more at two-week intervals.
  • Serum was collected from the rabbits and assayed for anti-chitinase antibodies by ELISA. The results obtained showed that both of the rabbits possessed high serum titers of anti- chitinase antibodies. Resulting serum obtained from the animals was stored at -30°C and used in connection with assays such as those described below.
  • Anti-chitinase antibodies are believed to be novel and therefore constitute another aspect of applicants' invention. Further, conjugates formed between anti-chitinase antibodies and enzymes capable of generating a colorant upon contact with a chromogenic solution include another aspect of applicants' invention. It should be pointed out that the anti-chitinase anti ⁇ bodies can be conjugated to other enzymes either directly or indirectly. As an example of such indirect conjuga ⁇ tion, other antibodies with respect to the anti-chitinase antibodies can be generated, which antibodies are connected to a label or enzyme capable of generating a color upon contact with a chromogenic solution.
  • the assay to detect the presence of chitin- containing fungi may be a direct binding assay.
  • the chitin-binding enzyme reagent, chitinase or lysozyme is reacted with chitin in fungi present in the sample, by contacting the sample attached to the solid phase with a labeled binding reagent.
  • the label is then visually detected to determine whether fungi are present.
  • the presence of fungi may be quantified, by using predetermined amounts of the labeled assay reagent and relating the intensity of the signal produced by the label (which is a function of the amount of assay reagent reacted) , to the concentration of chitin using standard binding curves. These curves are generated by measuring the intensity of the signal produced using known amounts of chitin.
  • the amount of chitin may also be quantified using an indirect, competitive inhibition assay in which a mixture of labeled assay reagent, for example chitinase, and organism-containing solution is mixed and then added to react with chitin attached to the solid support. Chitin-containing organisms will compete with the immobilized chitin and thus reduce the degree of signal produced by the label in a dose-related manner, permitting a determination of the amount of chitin present in the organisms in the sample.
  • an indirect, competitive inhibition assay in which a mixture of labeled assay reagent, for example chitinase, and organism-containing solution is mixed and then added to react with chitin attached to the solid support. Chitin-containing organisms will compete with the immobilized chitin and thus reduce the degree of signal produced by the label in a dose-related manner, permitting a determination of the amount of chitin present in the organisms in the sample.
  • Visualization of the binding of the assay reagent to chitin present in the sample may be accomplished by directly labeling the chitinase directly or indirectly with a substance capable of producing a signal, for example, a radionuclide, enzyme or a fluorescent agent, using known procedures. If an enzyme label is employed, an enzyme is selected which when reacted with its appropriate chromogenic reagent produces a color or other visibly detectable signal.
  • a soluble enzyme substrate such as orthophenylenediamine (OPD) reactive with the enzyme horseradish peroxidase (HRP) may be used.
  • the sample or specimen is applied manually to a solid phase such as a glass slide to be visualized.
  • a substrate such as diaminobenzidine or 3-amino-9-ethyl-carbazole and the HRP is used.
  • the colored, insoluble reaction product from the cleavage of the substrate by the enzyme will be deposited at or near the location of the enzyme.
  • the enzymatic reaction (of the enzyme label) will deposit the colored substrate around and on the fungal structure and allow the fungus to be readily detected by visual examination.
  • the chitin-binding enzyme assay reagent may be indirectly labeled, attaching the signal- producing label to an additional substance which binds to the assay reagent.
  • an anti-chitinase antibody may be conjugated with a label and bound to the chitinase for reacting with the chitin.
  • This assay may provide a more sensitive assay for the detection of the organism because more label can be bound per unit of assay reagent.
  • Biotin/avidin reagents may be used to accomplish binding. In this case, biotin is covalently bound to antibody, for example, anti-chitinase antibody.
  • biotin-specific receptor protein avidin is conjugated to a signal-generating enzyme, then reacted with biotin to label the antibody.
  • the labeled antibody is then used in an assay to detect chitinase bound to chitin in the sample being assayed.
  • Figure 2 involves binding chitinase to the substrate first. Regardless of which protocol is used, the chitin within the sample is eventually attached to a label or enzyme capable of generating a colorant thereby making it possible to visually determine the presence or absence of chitin within the sample.
  • the subgeneric embodiment shown within Figure 1 is essentially described in further detail by the specific embodiments shown schematically within Figures 3-6, described in detail below.
  • the subgeneric embodiment shown within Figure 2 is further described by reference to the specific schematic representation shown within Figure 7. It should be noted that although only one specific representation (Figure 7) is given with respect to the subgeneric embodiment of Figure 2, it is possible to rearrange the various components as per Figures 3-6 to drive specific embodiments of the subgeneric embodiment of Figure 2.
  • FIG. 3 A schematic of a particular embodiment of an assay of the invention is shown in Figure 3. This assay will be described in greater detail than the assays of Figure 4-7, which will be described more briefly in that specific information is given below with respect to Figure 3 which can be applied to the assay shown in Figures 4-7.
  • a sample to be tested for the presence of chitin is placed on the membrane surface such as the porous membrane shown.
  • the chitin in the sample is adhered to the membrane in some manner. This can be done by using any of the above-described methods. It is preferably done by passing the sample through a permeable membrane which acts as a filter and traps solids in the sample such as the chitin.
  • blocking reagents can make any of the assay embodiments of the invention more specific. Since the use of blocking proteins and blocking reagents in connection with such assays is known to those skilled in the art, the following description will not repeat the step with respect to the use of blocking reagents further.
  • a chitin-binding enzyme such as chitinase or lysozyme, is added to the sample to be assayed under conditions which allow the chitin-binding reagent to bind to chitin present in the sample.
  • the binding environment may be controlled so that the enzymes can bind to the chitin but not quickly degrade the chitin. Although some enzymatic degradation may occur, the system does not depend on degradation of the chitin to generate a signal and detection ability is maintained even though the chitin may be partially degraded. More specifically, the system takes advantage of the enzyme's own ability to specifically bind to the substrate chitin.
  • Antibodies to the chitin-binding reagent e.g., rabbit anti-chitinase antibody
  • a second enzyme is conjugated to an anti- antibody, i.e., an antibody against the first antibody.
  • alkaline phosphatase is conjugated to goat anti-rabbit IgG antibody. This is added to provide a second antigen-antibody reaction.
  • a reagent (substrate) for the conjugated antibody is added to generate a detection signal.
  • Substrates for alkaline phosphatase include bromo-chloro-indolyl phosphate and nitro blue tetrazolium in a buffer of aminoethyl propanediol. However, other chromogenic signals can be utilized.
  • the anti-chitinase-binding antibody itself can be conjugated to any label such as an enzyme capable of generating a color in combination with a chromogenic solution.
  • enzymes include urease and peroxidase.
  • ASSAY OF FIGURE 4 The schematic view of the assay shown in Figure 4 includes a support in the form of a porous membrane upon which the sample which putatively contains chitin is placed.
  • the chitin-binding enzyme such as chitinase is then added under conditions such that the chitinase can bind to any chitin present. Extraneous and unbound materials can then be washed away.
  • conjugate is then added which conjugate is comprised of an enzyme bound to rabbit anti-chitinase antibodies. If chitinase is present in that it is bound to chitin, the antibodies will bind to the chitinase. Unbound material is then washed away. Thereafter, a chromogenic solution is added to provide a color which can be visually detected.
  • FIGURE 5 the chitinase is bound to avidin to form a conjugate. After this conjugate is allowed to bind to the chitin due to the specificity of the chitinase, a biotinylated enzyme is added which is biotin-conjugated alkaline phosphatase. The biotinylated enzyme will bind to the advidin and any bound material can be detected at the addition of the chromogenic solution.
  • the essential component is the conjugate comprised of the chitinase bound to an enzyme such as alkaline phosphatase.
  • the chitinase will bind to any chitin present on the support. After the binding, washing takes place followed by the addition of a chromogenic solution which provides a color if the alkaline phosphatase is present.
  • Figure 7 is a specific embodiment of the subgeneric method shown in figure 2.
  • a chitin-binding enzyme such as chitinase is first bound to the surface of a solid support, such as a polystyrene support. It is not necessary to bind chitinase to all of the available support surface. Active sites which do not have chitinase bound thereto can be protected by the addition of any suitable blocking agent such as BSA. After the chitinase and blocking agents are added, the sample which might contain chitin is placed on the surface. If chitin is present in the sample, it will bind to the immobilized chitinase.
  • the surface is then washed and more chitinase is added, which will bind to any chitin attached to the surface immobilized chitinase.
  • an anti-chitinase antibody is added which binds to chitinase.
  • washing is carried out followed by the addition of a conjugate.
  • This conjugate is comprised of an enzyme such as alkaline phosphatase bound to an antibody which binds to the chitinase antibody.
  • an anti-antibody might be an anti-IgG antibody such as a goat anti-rabbit IgG antibody.
  • a chromogenic solution is added which generate a color after contacting the enzyme such as the alkaline phosphatase.
  • Figure 7 provides the only specific embodiment of the subgeneric embodiment of Figure 2, other specific embodiments encompassed by the general concept of Figure 2 will be apparent to those skilled in the art upon reading this disclosure and reviewing the specific embodiments shown in Figures 3-6. All of the embodiments include the use of a chitin-binding enzyme, such as chitinase, in order to bind chitin.
  • a chitin-binding enzyme such as chitinase
  • Different layering techniques involving other reagents such as antibodies and conjugates can be used in different forms and manners in order to obtain different desired effects.
  • Various conjugates useful in connection with the assays of the invention are also considered to be aspects of the present invention. Different conjugates can be formed using methodology known to those skilled in the art. With respect to the formation of specific antibody to enzyme conjugates, reference is made to the Sigma catalog relating to immunochemicals published in
  • Such conjugates can include chitinase/other enzyme antibodies which other enzymes are generally enzymes capable of generating a color when brought into contact with a chromogenic solution.
  • Anti-chitinase antibodies can also be conjugated to other antibodies which in turn are conjugated to other enzymes which are capable of generating a color upon contact with a chromogenic solution.
  • labeling agents other than enzymes such as radionuclides or fluorescing agents, may be used to detect the reagent bound to chitin using procedures known in the art.
  • samples may be attached to a substrate by other procedures, for example filtration of a fluid sample and centrifugation of materials onto a solid phase.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Stored Programmes (AREA)
  • Programmable Controllers (AREA)

Abstract

On décrit un procédé de détection d'organismes contenant de la chitine, tels que les champignons, la levure et les insectes, dans un échantillon fixé à une phase solide, et qui consiste à détecter la présence de la chitine au moyen d'enzymes qui se lient spécifiquement avec celle-ci. Le procédé consiste de préférence à faire passer l'échantillon contenant la chitine à travers une membrane afin de piéger et de faire adhérer la matière chitineuse à la membrane. Une enzyme qui se lie à la chitine, telle que la chitinase ou la lysozyme, est ajoutée dans des conditions qui lui permettent de se lier à la chitine sur la membrane. Un composé produisant un signal est soit directement conjugué avec la chitinase (ou lysozyme), soit indirectement conjugué avec un anticorps anti-chitinase (ou lysozyme) ou avec un anticorps anti-IgG (qui se lie avec l'anticorps anti-chitinase), afin de détecter le complexe chitine-chitinase. Des réactifs destinés au composé produisant un signal sont alors ajoutés afin de produire un signal de détection indiquant la présence de la chitine. Des kits contenant les matériaux nécessaires pour effectuer les procédés de l'invention sont aussi décrits, ainsi que de nouveaux conjugués.A method of detecting organisms containing chitin, such as fungi, yeast and insects, in a sample attached to a solid phase is described, which consists in detecting the presence of chitin by means of enzymes which specifically bind to it. The method preferably involves passing the sample containing the chitin through a membrane to trap and adhere the chitinous material to the membrane. An enzyme that binds to chitin, such as chitinase or lysozyme, is added under conditions that allow it to bind to chitin on the membrane. A signal producing compound is either directly conjugated with chitinase (or lysozyme), or indirectly conjugated with an anti-chitinase antibody (or lysozyme) or with an anti-IgG antibody (which binds with the anti-chitinase antibody), in order to detect the chitin-chitinase complex. Reagents for the signal producing compound are then added to produce a detection signal indicating the presence of chitin. Kits containing the materials necessary to carry out the methods of the invention are also described, as well as new conjugates.

Description

ASSAY DEVICE AND METHOD OF DETECTING CHITIN
Field of the Invention
This invention relates to the field of assays to detect target substances, and particularly to assays to determine the presence of chitin and thereby determine the presence of organisms which contain chitin such as fungi, yeast, and insects in a sample.
Bac crround Infections caused by fungi and yeast affect animals including humans and plants worldwide. There exist a large number of such organisms which can contaminate water and food supplies and cause infections in various body tissues and fluids. Conventional methods to detect the presence of contaminating fungi, yeast and insects require obtaining samples from an animal or plant suspected of containing these organisms and culturing the samples to grow the desired organisms present in the sample in sufficient numbers to readily detect their presence visually.
Typically, culturing the organisms requires specialized media and lengthy culture times of up to several weeks. Other methods involve the use of a hot basic solution such as a 20% potassium hydroxide to clear smears of specimens on a solid substrate. The cleared specimen is then stained, for example using India ink, then examined by microscope to detect the presence of fungal structures remaining after this treatment. Fungi, yeasts and insects contain certain substances, including proteins, that may be specific for a particular species. Other substances are more widely distributed. For example, chitin (N-acetylglucosamine oligomer) is a polysaccharide component of cell walls found in most fungi, yeasts and insects and is reactive with reagents such as lectins (Galun et al., Arch.
Microbiol.. 108(1) :9-16 (1976)).
Assays for the presence of chitin-containing organisms such as fungi are known but have been limited to the detection of chitin using chemical analyses including colorimetric determination (Shar a et al..
Trans. Br. Mvcol. Soc.. 69(3):479-83 (1977)) and the use of nitrous acid-3-methyl-2-benzothiazolinone hydrazone hydrochloride-ferric chloride and light microscopy
(Kaminskyj et al., Can. J. Bot.. 60(12) :2575-80 (1982)).
Immunological assays to detect various microorganisms including fungi using antibodies are also known, including those employing monoclonal antibodies reactive with antigens associated with particular organisms.
(Goldstein, European Patent Application EP 176,355
(1986)). Such assays are based on species-specific proteins. In addition, to detect the organism the assays typically require that the specific protein be isolated or exposed for reaction with the antibody in the assay.
Labeled chitinase has been reported to be useful for visualization of chitin with electron and fluorescence microscopy. Chamberland et al.,
Histochemical Journal, 17:313-321 (1985), reported the use of a chitinase-gold complex to localize chitin ultrastructure in tomato root cells infected by Fusarium sp. to study host-pathogen relationships. Molano et al.,
J. Cell Biol.. £5:199-212 (1980), reported the use of chitinase-gold complex to study the distribution of chitin in Saccharomvces cerevisiae. Both techniques require the use of an electron microscope for visualization. Molano et al. also reported the use of fluorescein isothiocyanate (FITC)-chitinase to visualize chitin with fluorescence microscopy.
Hadwiger et al., Plant Physiol. , 67:170-175 (1981) , reported the use of anti-chitosan and anti-fungal cell wall antisera to study the localization of fungal components in pea-Fusarium interaction. The antisera were conjugated with FITC. Therefore, to detect chitin in the tissue, the samples had to be examined with a UV microscope. Embedding and immunochemical staining of sections were also prepared for transmission electron microscopy. Procedures such as described by Chamberland et al., Molano et al., and Hadwiger et al. necessitate microscopy to visualize the chitin in the sample. These procedures usually were accompanied by elaborate sample preparation methods.
U.S. application serial no. 426,538, filed October 24, 1989 (incorporated herein by reference) , disclosed a method of detection of fungi, yeasts and insects without requiring in vivo or in vitro culturing techniques or complex staining reagents, which method relied on lectin or chitin antibodies to target the chitin. The present invention offers substantial improvements over this method.
Summary of the Invention
The basic inventive concept of the assay methods and means for carrying out those methods is based on the recognition that certain organisms including fungi, yeasts and insects are rich in chitin.
Accordingly, the assay of the invention is for the direct detection of chitin and by implication deducing the presence of the chitin-containing organisms. An essential feature of the present invention is that it involves the use of enzymes which specifically bind to chitin. Such enzymes are referred to as chitin-binding biological reagents and chitin-binding or chitin-specific enzymes and include chitinase and lysozyme. Such chitin- binding enzymes are directly or indirectly attached to a label before or after they bind to chitin. Thereby the assays of the invention can be used to selectively attach detectable labels to chitin present within a sample.
The assay of the invention makes it possible to detect chitin by the use of enzymes which specifically bind chitin. Although the invention can be described in terms of several different specific embodiments, such specific embodiments can be generally classified under two subgeneric embodiments. More specifically, in accordance with one subgeneric embodiment, an enzyme which specifically binds chitin, such as chitinase, is bound to the surface of a support such as the bottom of a icrotiter plate well, the surface of a glass slide or the surface of a dipstick. Samples to be tested are then brought in contact with the enzyme, bound to the surface and various procedures are carried out in order to determine and detect the presence of any chitin binding to the enzyme on the surfaces. In accordance with a second subgeneric embodiment, a fluid sample or a fluidized sample is filtered through a membrane in order to capture the solid components of the sample on the surface of the membrane. Accordingly, any chitin- containing organisms, chitin, or fragments thereof within the sample become bound to the membrane surface. The bound sample is then contacted with an enzyme capable of selectively binding to any chitin in the sample, for example chitinase or lysozyme. The chitin-binding enzyme may be directly or indirectly labeled to permit detec¬ tion. The presence of the chitin-containing organisms such as fungi is determined by visually detecting the label with the naked eye. A primary object of the present invention is to provide a rapid detection assay which uses a chitin- binding enzyme for determining the presence of'chitin- containing organisms without the need for in vitro or in vivo culture techniques or time-consuming staining procedures.
A feature of the present invention is that the assay detects the cellular chitin component of all organisms containing chitin such as fungi, yeasts and insects, which chitin component is generally absent in bacteria and mammalian and plant tissue, reducing possible false positive readings.
An advantage of the present invention is that it can be used to detect chitin and deduce the presence of chitin-containing organisms in samples of all types of biological (mammalian and plant) fluids and tissues as well as food and water without the need for any culturing techniques or staining procedures. The method is not limited to particular species of fungi, yeasts or insects since all such organisms contain chitin. Another advantage of the present invention is that it provides an efficient, economical, clinical laboratory assay technique for the rapid diagnosis of fungal infections in patients.
Another feature of the present invention is that it provides an assay procedure which can be used by agricultural and food laboratories to evaluate field samples for the presence of fungi, insects, and related pathogens and contaminants. Another object of the invention is to provide a portable (preferably disposable) diagnostic kit which can be used to detect the presence of chitin-containing organisms in an efficient and economic manner. Another feature of the present invention is that the fungal contaminants do not have to be directly cultured nor do they require the use of classical chemical staining procedures for the localization of the contaminants. Another feature of the present invention is that neither lectins nor anti-chitin antibodies are used to detect chitin which is a desirable feature in that lectins will often bind nonspecifically to nonfungal carbohydrates other than chitin, whereas anti-chitin antibodies are undesirable in that they are, at best, difficult to generate due to chitin's poor immunogenicity.
An advantage of the present invention is that the detection means do not require the use of either electron or fluorescent microscopy to effect detection.
These and other objects, advantages and features of the present invention will become apparent to those persons skilled in the art upon reading the details of the structure and usage as more fully set forth below, references being made to the accompanying figures forming a part hereof.
Brief Description of the Drawings
The present invention will be described in connection with the accompanying drawings in which:
Figure 1 is a schematic view of an embodiment of the invention wherein the chitin is bound on a permeable membrane matrix; Figure 2 is a schematic view wherein the chitin-containing sample is present in a coated microtiter well;
Figure 3 is a schematic representation of the components of an assay scheme which includes a membrane support, chitinase, rabbit anti-chitinase antibody, and alkaline phosphatase conjugated to goat anti-rabbit IgG antibody, which enzyme can generate a colored product from a chromogenic solution; Figure 4 is a schematic representation of the components of another assay embodiment of the invention wherein the porous membrane captures the chitin, a chitin-binding enzyme attaches to the bound chitin, thereafter a conjugate comprised of a signal generating enzyme bound to an antibody reactive with the chitin- binding reagent binds to the chitin-binding reagent and a chromogenic solution is added, which solution contains the substrate for the signal generating enzyme, which substrate releases a color when contacted with the enzyme;
Figure 5 is a schematic representation of the components of yet another embodiment of an assay of the invention which includes a support having bound thereto chitin having bound thereto avidin-conjugated chitin- binding biological reagent having bound thereto biotinylated enzyme and a chromogenic solution;
Figure 6 is a schematic view of the components of yet another embodiment of the assay of the invention wherein a solid support has thereon chitin which has bound thereto an enzyme-conjugated chitin-binding biological reagent wherein the enzyme of the conjugate will react with its substrate in a chromogenic solution to form a colored product; and Figure 7 is a schematic view of the components of yet another embodiment of the assay of the invention which includes a chitin-binding biological reagent which is chitinase coated on a solid support, chitin bound to the coated support, chitin-binding biological reagent bound to the chitin, rabbit anti-chitin-binding reagent antibody bound thereto, an enzyme conjugated to goat anti-rabbit IgG antibody and a chromogenic solution.
Detailed Description of the Preferred Embodiments
Before the present method of detecting chitin- containing organisms such as fungi, yeasts and insects and assay devices and kits for carrying out such are described, it is to be understood that this invention is not limited to the particular methods, assay devices or kits described as such may, of course, vary. It is also to be understood that the terminology used herein is for the purpose of describing particular embodiments only, and is not intended to be limiting since the scope of the present invention will be limited only by the appended claims.
It must be noted that as used in this specification and the appended claims, the singular forms "a," "an" and "the" include plural referents unless the context clearly dictates otherwise. Thus, for example, reference to "an enzyme" includes mixtures of enzymes, reference to "a sample for testing" includes reference to mixtures of such samples and reference to "the method" includes one or more of the methods described and so forth.
The method of the present invention allows the rapid detection of the presence of a variety of chitin- containing organisms including fungi, yeast and insects, without requiring costly and time-consuming culturing or staining of the organisms. The method provides an assay for detecting chitin using chitin-specific enzyme reagents and is not limited to any particular strain or species of organism. In addition, the method does not require that specific substances such as proteins or carbohydrates be isolated from a sample suspected of containing organisms, prior to detection in the assay.
The substance that is detected in the method of this invention is chitin, an N-acetyl-glucosamine oligomer present in the cell walls of nearly all fungi and yeasts as well as the exoskeleton of many insects and other arthropods.
To carry out the invention, a sample suspected of containing target organisms is obtained. The sample may include a fluid and non-fluid component and may originate from humans, animals, plants or food items. Typical samples include biological fluids such as urine, spinal fluid, whole blood or serum. Other samples include biological specimens such as skin scrapings, sputum, tissue homogenates, wound exudates, or hair. In addition, samples may consist of materials from plants including tissue, scrapings, fluids, exudates and homogenates, or may be water or food suspected of contamination. Depending upon the type of sample obtained, different embodiments of the invention are more readily applicable for assaying for the presence of chitin in the sample. Although the invention includes a wide variety of different possible embodiments and different chemical and biological reagents which can be used in connection with each of these embodiments, the invention is generally encompassed by two subgeneric embodiments. In accordance with the first subgeneric embodiment, the sample includes fluid and nonfluid components or is fluidized so as to contain both components and is thereafter filtered through a porous membrane in order to capture the nonfluid-containing components on the surface of the membrane. The presence of chitin in these nonfluid-containing components is then assayed by the use of an enzyme which specifically binds to chitin. This subgeneric embodiment is generally shown within Figure l and specific embodiments thereof are schematically represented within Figures 3-6. The second subgeneric embodiment of the invention involves coating the surface of a material such as a microtiter well with an enzyme which specifically binds to chitin. Once the enzyme such as chitinase has been bound to the surface, the sample to be assayed is brought into contact with the bound chitinase for a sufficient period of time to allow binding to occur between any chitin in the sample and the chitinase bound to the surface. This subgeneric embodiment of the invention is shown within Figure 2. A specific embodiment schematically demonstrating how this subgeneric embodiment can be carried out is shown within Figure 7. However, it should be noted that by various manipulations which will be apparent to those skilled in the art, the subgeneric embodiment shown within Figure 2 can also be carried out using the specific embodiments shown within Figures 3-6, i.e., it need not be carried out only using the specific embodiment of Figure 7. When the chitin-specific enzyme is to be adhered to a substrate surface, it may be adhered to the surface of a glass slide, microtiter well, dipstick or other suitable material. When the sample is to be filtered through a membrane, any suitable membrane filter can be used, such as those composed of various synthetic or natural polymeric materials. The two subgeneric embodiments of the invention are shown in figures 1 and 2. In figure 1, the solid components of a sample comprised of liquid and solid components have been attached to a membrane matrix. Various specific embodiments are shown in figures 3-6. The surface of the matrix is preferably designed such that it will hold the solid components and particularly the chitin within the sample securely in place on the surface of the matrix. It is often desirable to include a blocking agent (described further below) to protect active binding sites that have not been occupied by chitin. After the sample has been secured to the matrix, different procedures are carried out whereby a signal (preferably a visually-observable color signal) is generated and the presence or absence of chitin is determined and thereby the presence or absence of chitin containing microorganisms are determined.
The sites on the surface of the membrane which do not have chitin bound thereto are preferably blocked, for example by incubation of the fixed sample on the membrane with an irrelevant protein solution such as bovine serum albumin (BSA) , casein or egg albumin. Blocking reduces any nonspecific interactions (i.e., electrostatic interactions) of the binding sites which may interfere with the assay to detect chitin.
In accordance with the embodiment shown in figure 2, the surface of the well is coated with a chitin-specific enzyme. A blocking agent is then applie to occupy all remaining binding sites of the well. A sample which may contain chitin is placed in the treated well surface. A specific embodiment is shown in figure
7. Chitinase is added and allowed to incubate with the sample for a time period in the range of about 3 minutes to about 1 hour to allow the chitinase to bind to any chitin present within the sample. The wells are then washed with a buffer to remove any chitinase which is not bound to chitin bound to chitinase on the surface of the microliter well. After the washing, any immobilized chitin on the well plate would be detected by adding a reagent which causes a color reaction after contacting a label connected directly or indirectly to the chitinase. This methodology can be used in connection with both insoluble and soluble signal detection strategies. That is, if an insoluble signal reagent is used, the signal will appear coated on the bottom and sides of the well. If a soluble signal reagent is used, the supernatant can be read visually with the naked eye .in situ or by highly reliable and commonly used automatic plate readers, or drawn off for processing in a separate detector.
The sample can also be manually smeared onto a glass slide with a cotton swab, scalpel blade, or other similar device, allowed to dry completely and then fixed with chemicals. Heat may also be used for fixation, for example, the solid phase may be placed over a boiling (100°C) water bath until the sample adheres onto the solid phase.
If the sample has no fluid component, it may be manually placed on the solid phase and adhered using chemical fixatives, or it may be suspended in a fluid and applied to a solid phase as described above.
The assay methodology of the present invention is based on the use of the chitin-specific enzyme which is directly or indirectly attached to a label. Accor- dingly, the assay of the invention can be used to detect chitin-containing organisms present in situ on a surface without having to remove or destroy the surface on which the organisms might be present. For example, if one sus¬ pects a plant to have a fungal infection on its surface, a biological reagent of the present invention containing a chitin-specific enzyme can be sprayed onto the surface of the plant. Thereafter, washing should be carried out in order to wash away any unbound chitin-specific enzyme. After washing, various procedures such as those shown within the specific embodiments of Figures 3-7 can be carried out in order to detect any chitin-specific enzyme bound to the chitin which might be present on the plant. Such a method might be carried out by using chitinase bound to another enzyme which generates a color when placed in contact with a chromogenic solution. Such a two-enzyme conjugate could be contacted with the plant surface, followed by washing, followed by the application of a chromogenic solution. If the surface changes color, such would indicate the presence of a chitin-containing organism on the plant surface.
The assay of the invention relies upon binding of a chitin-binding enzyme reagent specifically binding to chitin and the visualization of this binding by a labeling system. The binding reagent is preferably chitinase.
Polyclonal antibodies reactive with chitinase may be obtained by recovery of serum-containing antibodies following immunization of a mammalian host using chitinase as the immunogen. Procedures for producing polyclonal antibodies are well known and will not be repeated here. The serum-containing polyclonal antibodies are used for binding to chitinase which is bound to chitin in an assay described below to detect chitin-containing organisms.
Monoclonal antibodies reactive with chitinase may also be used in an assay to bind to chitinase. These monoclonal antibodies may be derived using known tech¬ niques following the procedures of Kohler and Milstein, Nature, 256:495 (1975), incorporated herein by reference, to disclose methods of obtaining monoclonal antibodies. In this procedure, hybrido as are prepared by fusing antibody-producing cells (typically spleen cells of mice previously immunized with an antigen) to cells from an immortal cell line such as myeloma cells, using somatic cell hybridization.
Although it has been found that chitin is substantially nonimmunogenic and that, therefore, it is difficult to generate chitin antibodies, it has been found that anti-chitinase antibodies can be generated and that such anti-chitinase antibodies are useful in accordance with different embodiments of the present invention. Polyclonal and/or monoclonal antibodies which are anti-chitinase antibodies are useful in carrying out different specific embodiments of the invention. We have generated polyclonal anti-chitinase antibodies in rabbits, which antibodies can be used in the detection of chitinase. Accordingly, if chitin is bound to a support surface and chitinase is added and then attaches to the chitin, these anti-chitinase antibodies will bind to the chitinase. Such anti-chitinase antibodies are generally labeled, such as with an enzyme, which enzyme generates a color when brought into contact with a chromogenic solution.
Polyclonal anti-chitinase antibodies were generated using two New Zealand White rabbits. The rabbits were immunized with 1 mg of chitinase from Streptomvces σriseus (obtainable from the Sigma catalog C1525) present in Ribi adjuvant. The rabbits received a second immunization three weeks later and were then immunized twice more at two-week intervals. Serum was collected from the rabbits and assayed for anti-chitinase antibodies by ELISA. The results obtained showed that both of the rabbits possessed high serum titers of anti- chitinase antibodies. Resulting serum obtained from the animals was stored at -30°C and used in connection with assays such as those described below. Anti-chitinase antibodies are believed to be novel and therefore constitute another aspect of applicants' invention. Further, conjugates formed between anti-chitinase antibodies and enzymes capable of generating a colorant upon contact with a chromogenic solution include another aspect of applicants' invention. It should be pointed out that the anti-chitinase anti¬ bodies can be conjugated to other enzymes either directly or indirectly. As an example of such indirect conjuga¬ tion, other antibodies with respect to the anti-chitinase antibodies can be generated, which antibodies are connected to a label or enzyme capable of generating a color upon contact with a chromogenic solution.
The assay to detect the presence of chitin- containing fungi, may be a direct binding assay. In such an assay the chitin-binding enzyme reagent, chitinase or lysozyme, is reacted with chitin in fungi present in the sample, by contacting the sample attached to the solid phase with a labeled binding reagent. The label is then visually detected to determine whether fungi are present. The presence of fungi may be quantified, by using predetermined amounts of the labeled assay reagent and relating the intensity of the signal produced by the label (which is a function of the amount of assay reagent reacted) , to the concentration of chitin using standard binding curves. These curves are generated by measuring the intensity of the signal produced using known amounts of chitin.
The amount of chitin may also be quantified using an indirect, competitive inhibition assay in which a mixture of labeled assay reagent, for example chitinase, and organism-containing solution is mixed and then added to react with chitin attached to the solid support. Chitin-containing organisms will compete with the immobilized chitin and thus reduce the degree of signal produced by the label in a dose-related manner, permitting a determination of the amount of chitin present in the organisms in the sample.
Visualization of the binding of the assay reagent to chitin present in the sample, may be accomplished by directly labeling the chitinase directly or indirectly with a substance capable of producing a signal, for example, a radionuclide, enzyme or a fluorescent agent, using known procedures. If an enzyme label is employed, an enzyme is selected which when reacted with its appropriate chromogenic reagent produces a color or other visibly detectable signal. In those instances where the enzyme substrate is to be used in solution to contact the enzyme-labeled reagent bound to the sample on the solid phase, a soluble enzyme substrate such as orthophenylenediamine (OPD) reactive with the enzyme horseradish peroxidase (HRP) may be used.
In accordance with another method the sample or specimen is applied manually to a solid phase such as a glass slide to be visualized. A substrate such as diaminobenzidine or 3-amino-9-ethyl-carbazole and the HRP is used. The colored, insoluble reaction product from the cleavage of the substrate by the enzyme will be deposited at or near the location of the enzyme. Thus when a fungal structure is coated with enzyme-labeled chitinase, the enzymatic reaction (of the enzyme label) will deposit the colored substrate around and on the fungal structure and allow the fungus to be readily detected by visual examination. Alternately, the chitin-binding enzyme assay reagent may be indirectly labeled, attaching the signal- producing label to an additional substance which binds to the assay reagent. For example, where chitinase is used to detect the chitin, an anti-chitinase antibody may be conjugated with a label and bound to the chitinase for reacting with the chitin. This assay may provide a more sensitive assay for the detection of the organism because more label can be bound per unit of assay reagent. Biotin/avidin reagents may be used to accomplish binding. In this case, biotin is covalently bound to antibody, for example, anti-chitinase antibody. The biotin-specific receptor protein avidin is conjugated to a signal-generating enzyme, then reacted with biotin to label the antibody. The labeled antibody is then used in an assay to detect chitinase bound to chitin in the sample being assayed.
SPECIFIC ASSAY EMBODIMENTS The general or subgeneric embodiments of the assay described herein are shown in Figures 1 and 2.
Although both of these subgeneric embodiments involve the use of a chitin-binding enzyme such as chitinase, the protocol as shown in Figure 1 involves binding the sample to the substrate first whereas the protocol shown in
Figure 2 involves binding chitinase to the substrate first. Regardless of which protocol is used, the chitin within the sample is eventually attached to a label or enzyme capable of generating a colorant thereby making it possible to visually determine the presence or absence of chitin within the sample. The subgeneric embodiment shown within Figure 1 is essentially described in further detail by the specific embodiments shown schematically within Figures 3-6, described in detail below. The subgeneric embodiment shown within Figure 2 is further described by reference to the specific schematic representation shown within Figure 7. It should be noted that although only one specific representation (Figure 7) is given with respect to the subgeneric embodiment of Figure 2, it is possible to rearrange the various components as per Figures 3-6 to drive specific embodiments of the subgeneric embodiment of Figure 2.
ASSAY OF FIGURE 3
A schematic of a particular embodiment of an assay of the invention is shown in Figure 3. This assay will be described in greater detail than the assays of Figure 4-7, which will be described more briefly in that specific information is given below with respect to Figure 3 which can be applied to the assay shown in Figures 4-7. In accordance with the assay of Figure 3, a sample to be tested for the presence of chitin is placed on the membrane surface such as the porous membrane shown. The chitin in the sample is adhered to the membrane in some manner. This can be done by using any of the above-described methods. It is preferably done by passing the sample through a permeable membrane which acts as a filter and traps solids in the sample such as the chitin.
Once the sample is secured to a porous membrane, it is desirable to block other binding sites on the membrane by the addition of an irrelevant protein solution such as BSA. The use of such blocking reagents can make any of the assay embodiments of the invention more specific. Since the use of blocking proteins and blocking reagents in connection with such assays is known to those skilled in the art, the following description will not repeat the step with respect to the use of blocking reagents further.
A chitin-binding enzyme, such as chitinase or lysozyme, is added to the sample to be assayed under conditions which allow the chitin-binding reagent to bind to chitin present in the sample. The binding environment may be controlled so that the enzymes can bind to the chitin but not quickly degrade the chitin. Although some enzymatic degradation may occur, the system does not depend on degradation of the chitin to generate a signal and detection ability is maintained even though the chitin may be partially degraded. More specifically, the system takes advantage of the enzyme's own ability to specifically bind to the substrate chitin. Antibodies to the chitin-binding reagent (e.g., rabbit anti-chitinase antibody) can now be bound to the chitin-chitinase complex in order to provide the first antigen-antibody reaction.
A second enzyme is conjugated to an anti- antibody, i.e., an antibody against the first antibody. For example, alkaline phosphatase is conjugated to goat anti-rabbit IgG antibody. This is added to provide a second antigen-antibody reaction. Finally, a reagent (substrate) for the conjugated antibody is added to generate a detection signal. Substrates for alkaline phosphatase include bromo-chloro-indolyl phosphate and nitro blue tetrazolium in a buffer of aminoethyl propanediol. However, other chromogenic signals can be utilized. Alternatively, the anti-chitinase-binding antibody itself can be conjugated to any label such as an enzyme capable of generating a color in combination with a chromogenic solution. Such enzymes include urease and peroxidase. ASSAY OF FIGURE 4 The schematic view of the assay shown in Figure 4 includes a support in the form of a porous membrane upon which the sample which putatively contains chitin is placed. The chitin-binding enzyme such as chitinase is then added under conditions such that the chitinase can bind to any chitin present. Extraneous and unbound materials can then be washed away. A conjugate is then added which conjugate is comprised of an enzyme bound to rabbit anti-chitinase antibodies. If chitinase is present in that it is bound to chitin, the antibodies will bind to the chitinase. Unbound material is then washed away. Thereafter, a chromogenic solution is added to provide a color which can be visually detected.
ASSAY OF FIGURE 5 In Figure 5, the chitinase is bound to avidin to form a conjugate. After this conjugate is allowed to bind to the chitin due to the specificity of the chitinase, a biotinylated enzyme is added which is biotin-conjugated alkaline phosphatase. The biotinylated enzyme will bind to the advidin and any bound material can be detected at the addition of the chromogenic solution.
ASSAY OF FIGURE 6 A very simple embodiment of an assay of the invention is shown within Figure 6. In accordance with this embodiment, the essential component is the conjugate comprised of the chitinase bound to an enzyme such as alkaline phosphatase. The chitinase will bind to any chitin present on the support. After the binding, washing takes place followed by the addition of a chromogenic solution which provides a color if the alkaline phosphatase is present.
ASSAY OF FIGURE 7 The assay embodiment schematically shown within
Figure 7 is a specific embodiment of the subgeneric method shown in figure 2. In accordance with this embodiment, a chitin-binding enzyme such as chitinase is first bound to the surface of a solid support, such as a polystyrene support. It is not necessary to bind chitinase to all of the available support surface. Active sites which do not have chitinase bound thereto can be protected by the addition of any suitable blocking agent such as BSA. After the chitinase and blocking agents are added, the sample which might contain chitin is placed on the surface. If chitin is present in the sample, it will bind to the immobilized chitinase. The surface is then washed and more chitinase is added, which will bind to any chitin attached to the surface immobilized chitinase. After allowing the chitinase to bind to the chitin, an anti-chitinase antibody is added which binds to chitinase. After the antibody is allowed to bind, washing is carried out followed by the addition of a conjugate. This conjugate is comprised of an enzyme such as alkaline phosphatase bound to an antibody which binds to the chitinase antibody. For example, such an anti-antibody might be an anti-IgG antibody such as a goat anti-rabbit IgG antibody. After binding takes place and washing has been carried out, a chromogenic solution is added which generate a color after contacting the enzyme such as the alkaline phosphatase.
Although Figure 7 provides the only specific embodiment of the subgeneric embodiment of Figure 2, other specific embodiments encompassed by the general concept of Figure 2 will be apparent to those skilled in the art upon reading this disclosure and reviewing the specific embodiments shown in Figures 3-6. All of the embodiments include the use of a chitin-binding enzyme, such as chitinase, in order to bind chitin. Different layering techniques involving other reagents such as antibodies and conjugates can be used in different forms and manners in order to obtain different desired effects. Various conjugates useful in connection with the assays of the invention are also considered to be aspects of the present invention. Different conjugates can be formed using methodology known to those skilled in the art. With respect to the formation of specific antibody to enzyme conjugates, reference is made to the Sigma catalog relating to immunochemicals published in
1991 and to the various publications cited therein. Such publications describe the formation of specific conjugates such as enzyme/antibody conjugates, conjugates formed between alkaline phosphatase and other enzymes or antibodies, conjugates formed between peroxidase and other enzymes or antibodies, as well as conjugates formed between urease and other enzymes or antibodies. Specific descriptions are given with respect to the formation of biotin conjugates. The description contained within the Sigma catalog, as well as the various publications cited in that catalog, are incorporated herein by reference. An important aspect of applicants' invention involves the anti-chitinase antibodies which are produced in accordance with the methods described above. Various conjugates formed using these anti-chitin antibodies are also considered to be an important aspect of the present invention. Such conjugates can include chitinase/other enzyme antibodies which other enzymes are generally enzymes capable of generating a color when brought into contact with a chromogenic solution. Anti-chitinase antibodies can also be conjugated to other antibodies which in turn are conjugated to other enzymes which are capable of generating a color upon contact with a chromogenic solution.
As will be apparent to those skilled in the art to which the invention is addressed, the present invention may be carried out by using techniques other than those specifically discussed above without departing from the spirit or essential characteristics of the invention. The particular materials and processes described above are therefore to be considered in all respects as illustrative and not restrictive. For example, labeling agents other than enzymes, such as radionuclides or fluorescing agents, may be used to detect the reagent bound to chitin using procedures known in the art. In addition, samples may be attached to a substrate by other procedures, for example filtration of a fluid sample and centrifugation of materials onto a solid phase. The scope of the present invention is as set forth in the appended claims rather than being limited to the examples of the methods and procedures set forth in the foregoing description.

Claims

What is claimed is:
1. A method for determining the presence of chitin in a sample, comprising: a) attaching a sample suspected of containing chitin to a substrate; b) contacting the sample attached to the substrate with an enzyme capable of selectively binding chitin; and c) detecting any enzyme bound to chitin present in the sample, whereby the presence of a chitin is determined.
2. The method as claimed in claim 1, wherein the enzyme is bound to a label visually detectable with the unaided eye to form an enzyme-label conjugate.
3. The method as claimed in claim 2, wherein the enzyme is directly bound to the label.
4. The method as claimed in claim 2, wherein the enzyme is indirectly bound to the label by means of an intermediate compound or antibody.
5. The method as claimed in claim 2, wherein the enzyme is indirectly bound to the label via an anti- chitinase antibody.
6. The method as claimed in claim 2, wherein the enzyme is indirectly bound to the label via an anti- chitinase antibody and an anti-IgG antibody.
7. The method as claimed in claim 1, wherein the enzyme is selected from the group consisting of chitinase and lysozyme.
8. The method as claimed in claim 7, wherein the enzyme is chitinase.
9. The method as claimed in claim 2, wherein the label is an enzyme capable of generating a signal when brought into contact with a chromogenic solution.
10. The method of claim 1 wherein the sample is a biological fluid from a human.
11. The method of claim 10 wherein the biological fluid is selected from the group consisting of urine, blood, sputum and spinal fluid.
12. The method of claim 1 wherein the sample is selected from the group consisting of skin, sputum, tissue homogenates, exudates, and hair.
13. The method of claim 1 wherein the sample is water putatively contaminated with a chitin-containing organism.
14. The method of claim 1 wherein the sample is food putatively contaminated with a chitin containing organism.
15. The method of claim 1 wherein the sample is obtained from a plant putatively contaminated with a chitin-containing organism.
16. The method as claimed in claim 1, wherein the sample comprises fluidized plant tissue putatively containing insects.
17. The method of claim 1 wherein the substrate is selected from the group consisting of filters, membranes, beads, particles, microtiter plates, slides and magnetic particles.
18. The method of claim 1 wherein the substrate is comprised of a permeable polymeric material.
19. A method for determining the presence of chitin-containing organisms in a sample, comprising the steps of:
(a) attaching a sample suspected of containing chitin-containing organisms to the surface of a substrate;
(b) contacting the sample attached to the substrate with an enzyme capable of selectively binding chitin which enzyme is selected from the group consisting of chitinase and lysozyme; and
(c) detecting any enzyme bound to chitin present in the sample, whereby the presence of a chitin- containing organism is determined.
20. The method as claimed in claim 19 wherein the chitin-containing organism is an organism selected from the group consisting of fungi, yeast and insects.
21. A method of determining the presence of chitin in a sample, comprising the steps of:
(a) attaching an enzyme capable of selectively binding chitin to the surface of a substrate; (b) contacting the enzyme with a sample suspected of containing chitin for a sufficient time to allow any chitin in the sample to bind to the enzyme; and
(c) detecting any chitin bound to enzyme bound on the surface of the substrate, whereby the presence of chitin in the sample is determined.
22. The method as claimed in claim 21, further comprising: contacting any chitin bound on the enzyme with enzyme capable of selectively binding chitin; and contacting a conjugate comprised of an antibody conjugated to a label wherein the antibody is capable of selectively binding to the enzyme which selectively binds to chitin.
23. A chitin-detection assay kit, comprising:
(a) chitinase;
(b) an anti-chitinase-binding antibody; and (c) an anti-IgG antibody conjugated with a signal-generating enzyme.
24. The chitin-detection assay kit as claimed in claim 23, further comprising: (d) a chromogenic solution which generates a color in contact with the signal generating enzyme.
25. A chitin-detection assay kit, comprising: (a) lysozyme; (b) an anti-lysozyme-binding antibody; and
(c) an anti-IgG antibody conjugated with a signal-generating enzyme.
26. The chitin-detection assay kit as claimed in claim 25, further comprising:
(d) a chromogenic solution which generates a color in contact with the signal-generating enzyme.
27. A chitin-detection assay kit, comprising: (a) an enzyme capable of selectively binding to chitin, the enzyme being selected from the group consisting of chitinase and lysozyme; (b) an antibody which selectively binds to the enzyme capable of selectively binding to chitin; and
(c) an anti-IgG antibody which binds to the antibody (b) , the anti-IgG antibody being conjugated to a signal-generating enzyme.
28. A method for determining the presence of chitin on the surface of a plant, comprising:
(a) contacting the surface of the plant suspected of containing chitin with a reagent containing a chitin-binding enzyme selected from the group consisting of chitinase and lysozyme;
(b) washing the surface of the plant in order to wash away any enzyme not bound to chitin on the surface of the plant; (c) contacting the surface of the plant with an anti-chitase-binding antibody which antibody is bound directly or indirectly to a signal-generating enzyme;
(d) washing the surface of the plant in order to wash away any unbound signal-generating enzyme; and (e) contacting the surface of the plant with a chromogenic solution containing a substrate which generates a colored product when brought into contact with the signal-generating enzyme.
29. A method for determining the presence of chitin-containing organisms in the sample, comprising: a) attaching a sample suspected of containing chitin-containing organisms onto a support base; b) contacting the sample attached to the support base with chitinase; c) contacting the chitinase with an anti- chitinase-binding antibody; d) contacting the anti-chitinase-binding antibody with anti-IgG antibody conjugated with a reagent capable of generating a detection signal; and e) determining the presence or absence of the signal and thereby deducing the presence or absence of chitin in the sample and the presence or absence of chitin-containing organisms in the sample.
30. The method as claimed in claim 29, wherein the sample is a biological fluid from a human.
31. The sample as claimed in claim 30, wherein the biological fluid is selected from the group consisting of urine, blood and spinal fluid.
32. A conjugate comprised of chitinase bound to the signal-generating enzyme.
33. The conjugate as claimed in claim 30, wherein the chitinase is directly bound to the signal- generating enzyme.
34. The conjugate as claimed in claim 30, wherein the chitinase is bound to an anti-chitinase antibody which is bound to the signal-generating enzyme.
EP19920909933 1991-04-01 1992-03-30 Assay device and method of detecting chitin Withdrawn EP0532737A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67813491A 1991-04-01 1991-04-01
US678134 1991-04-01

Publications (1)

Publication Number Publication Date
EP0532737A1 true EP0532737A1 (en) 1993-03-24

Family

ID=24721526

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19920909933 Withdrawn EP0532737A1 (en) 1991-04-01 1992-03-30 Assay device and method of detecting chitin

Country Status (4)

Country Link
EP (1) EP0532737A1 (en)
JP (1) JPH05508078A (en)
CA (1) CA2076021A1 (en)
WO (1) WO1992017786A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5587292A (en) * 1987-05-22 1996-12-24 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Diagnosis of fungal infections with a chitinase
US5518890A (en) * 1992-11-20 1996-05-21 Mccormick & Company, Inc. Method and apparatus for the quantitation and separation of contaminants from particulate materials
US5914239A (en) * 1995-11-15 1999-06-22 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Diagnosis of fungal infections, and a chitin-binding lectin useful in such diagnoses
WO1998033934A1 (en) * 1997-02-04 1998-08-06 Morten Miller Method of selectively determining a fungal biomass
US5935804A (en) * 1997-03-21 1999-08-10 Laine; Roger A. Method for detecting eubacteria in biological samples with catalytically inactive murein binding enzymes
US5997846A (en) * 1997-11-17 1999-12-07 Albert Einstein College Of Medicine Of Yeshiva University Method for detecting arthropods
WO2005005955A2 (en) * 2003-06-27 2005-01-20 New England Biolabs, Inc. Specific detection of chitin using chitin-binding domain
US9380781B2 (en) 2010-08-26 2016-07-05 Agrosavfe N.V. Compositions for seed treatment
NZ759799A (en) 2014-04-10 2022-12-23 MEP Equine Solutions LLC Method for the quantification of parasite eggs in feces

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2309440A1 (en) * 1973-02-26 1974-09-05 Katz METHOD OF ISOLATING LYSOZYME
LU85581A1 (en) * 1984-10-10 1986-06-11 Smb Lab MONOCLONAL ANTIBODY SETS AGAINST HUMAN LACTOFERRIN AND HUMAN LYSOZYME
US5004699A (en) * 1987-11-20 1991-04-02 Sri International Method to detect fungi and yeasts

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9217786A1 *

Also Published As

Publication number Publication date
WO1992017786A1 (en) 1992-10-15
JPH05508078A (en) 1993-11-18
CA2076021A1 (en) 1992-10-02

Similar Documents

Publication Publication Date Title
US5004699A (en) Method to detect fungi and yeasts
JP2986961B2 (en) How to detect the presence of microorganisms
US4675286A (en) Fetal cell separation and testing
US4200690A (en) Immunoassay with membrane immobilized antibody
JP3040162B2 (en) Methods for measuring analytes in biological fluids in the presence of substances that interfere with analyte assays
CN100419427C (en) Method and device for trichomonas detection
US8404479B2 (en) Simple membrane assay method and kit
US5137810A (en) Method of determining the gram sign of bacteria
JP2004529350A (en) Candida Detection
JPS5972059A (en) Method of examining antigen and examining tool
IE63426B1 (en) Immunometric assay kit and method applicable to whole cells
EP0532737A1 (en) Assay device and method of detecting chitin
EP0777861B1 (en) Test kit and method for detection of target cells and molecules
JPS61286757A (en) Method of diagnosing syphilis
JP2021517242A (en) How to detect MAGEA4
FI83669B (en) FOERFARANDE FOER SPECIFIK BESTAEMNING AV PANKREAS -AMYLAS.
US4607008A (en) Enzyme/immunofluorescent assay for anti-Epstein-Barr Virus antibodies
JPS62276465A (en) Method and reagent for diagnosing gonorrhe and meningitis
US4582699A (en) Assay of immunoglobulin A protease and the rapid diagnosis of gonorrhea
US4645737A (en) Enzyme/immunofluorescent assay for anti-treponemal antibodies
EP0152254A2 (en) Chromogenic support immunoassay utilizing labeled complement components
JP2549305B2 (en) Independent multiplex immunoassay diagnostic system
Bosompem et al. Differentiation between culture-derived insect stages of T. brucei, T. vivax, T. congolense and T. simiae using a monoclonal antibody-based dot–ELISA
RU2737776C1 (en) Test kit for detecting cholera toxin in cultivation medium
WO1992014156A1 (en) Immunofluorescent test for mycobacterial antigens in biological fluids

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19921007

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): DE FR GB IT NL

17Q First examination report despatched

Effective date: 19950301

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19960618